| HOME >> BIOLOGY >> TECHNOLOGY |
Costs and expenses:
Cost of goods sold 3,951,607 3,878,214 7,874,193 7,508,594
Research and development 876,750 1,080,950 1,800,111 1,794,555
Marketing, general and
administrative 3,372,353 3,144,611 6,312,261 6,700,511
Total costs and
expenses 8,200,710 8,103,775 15,986,565 16,003,660
Loss from operations (705,630) (467,035) (1,598,214) (1,198,760)
Other (expense) and
income:
Equity in Ocular
Telehealth Management,
LLC (16,611) (12,155) (50,722) (30,698)
Interest income 85,391 13,498 187,088 58,934
Interest expense (2,496) (5,654) (6,289) (14,939)
Total other income 66,284 (4,311) 130,077 13,297
Net (loss) before taxes (639,346) (471,346) (1,468,137) (1,185,463)
Benefit from income taxes - (1,243) 0 (1,243)
Net (loss) $(639,346) $(470,103) $(1,468,137) $(1,184,220)
Basic net (loss) per
share $(0.10) $(0.07) $(0.23) $(0.19)
Diluted net (loss) per
share $(0.10) $(0.07) $(0.23) $(0.19)
Weighted average shares
- basic 6,389,315 6,347,972 6,388,701 6,346,315
Weighted average shares
- diluted 6,389,315 6,347,972 6,388,701 6,346,315
SELECTED BALANCE SHEET DATA:
December 31, June 30,
2007 2007
Cash, cash equivalents and Investments $7,527,023 $8,879,462
Total current assets $20,063,637 $21,763,012
Total assets
'/>"/>
| SOURCE Escalon Medical Corp. Copyright©2008 PR Newswire. All rights reserved |